{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:42:25Z","timestamp":1794627745951,"version":"4.9.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.amepre.2025.108102","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T03:41:47Z","timestamp":1765251707000},"page":"108102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Productivity Losses From Substance Use Disorder in the U.S. in 2023"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5314-8402","authenticated-orcid":false,"given":"Ramesh","family":"Ghimire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Florence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1553-661X","authenticated-orcid":false,"given":"Gery","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.amepre.2025.108102_bib0001","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/wps.21073","article-title":"Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention","volume":"22","author":"Volkow","year":"2023","journal-title":"World Psychiatry"},{"issue":"13","key":"10.1016\/j.amepre.2025.108102_bib0002","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.amepre.2025.108102_bib0003","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.amepre.2022.04.032","article-title":"Cost of cigarette smoking\u2012attributable productivity losses, U.S., 2018","volume":"63","author":"Shrestha","year":"2022","journal-title":"Am J Prev Med"},{"issue":"5","key":"10.1016\/j.amepre.2025.108102_bib0004","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.amepre.2015.05.031","article-title":"2010 national and state costs of excessive alcohol consumption","volume":"49","author":"Sacks","year":"2015","journal-title":"Am J Prev Med"},{"key":"#cr-split#-10.1016\/j.amepre.2025.108102_bib0005.1","unstructured":"Canadian Substance Use Costs and Harms Scientific Working Group, Canadian Substance Use Costs and Harms (2007-2014), 2018, Canadian Centre on Substance Use and Addiction"},{"key":"#cr-split#-10.1016\/j.amepre.2025.108102_bib0005.2","unstructured":"Ottawa. https:\/\/www.ccsa.ca\/sites\/default\/files\/2019-04\/CSUCH-Canadian-Substance-Use-Costs-Harms-Report-2018-en.pdf. Accessed June 20, 2025."},{"key":"10.1016\/j.amepre.2025.108102_bib0006","unstructured":"National Drug Intelligence Center, The Economic Impact of Illicit Drug Use on American Society, 2011, United States Department of Justice; Washington, D.C. https:\/\/www.justice.gov\/archive\/ndic\/pubs44\/44731\/44731p.pdf. Accessed June 22, 2025."},{"issue":"4","key":"10.1016\/j.amepre.2025.108102_bib0007","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1526-4637.2011.01075.x","article-title":"Societal costs of prescription opioid abuse, dependence, and misuse in the United States","volume":"12","author":"Birnbaum","year":"2011","journal-title":"Pain Med"},{"issue":"4","key":"10.1016\/j.amepre.2025.108102_bib0008","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s40258-014-0102-0","article-title":"Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims data","volume":"12","author":"Rice","year":"2014","journal-title":"Appl Health Econ Health Policy"},{"issue":"5","key":"10.1016\/j.amepre.2025.108102_bib0009","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/JOM.0000000000001830","article-title":"Opioid use disorder and employee work presenteeism, absences, and health care costs","volume":"62","author":"Henke","year":"2020","journal-title":"J Occup Environ Med"},{"issue":"10","key":"10.1016\/j.amepre.2025.108102_bib0010","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","article-title":"The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013","volume":"54","author":"Florence","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.amepre.2025.108102_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108350","article-title":"The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017","volume":"218","author":"Florence","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"15","key":"10.1016\/j.amepre.2025.108102_bib0012","doi-asserted-by":"crossref","first-page":"541","DOI":"10.15585\/mmwr.mm7015a1","article-title":"State-level economic costs of opioid use disorder and fatal opioid overdose\u2014United States, 2017","volume":"70","author":"Luo","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amepre.2025.108102_bib0013","unstructured":"Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health (NSDUH). https:\/\/www.samhsa.gov\/data\/data-we-collect\/nsduh-national-survey-drug-use-and-health. Accessed February 19, 2025."},{"key":"10.1016\/j.amepre.2025.108102_bib0014","unstructured":"Declercq E, Sakala C, Corry M, Applebaum S, Herrlich A. Listening to MothersSMIII: New Mothers Speak Out, 2013, Childbirth Connection; New York, NY.https:\/\/nationalpartnership.org\/wp-content\/uploads\/2023\/02\/listening-to-mothers-iii-new-mothers-speak-out-2013.pdf. Accessed June 20, 2025."},{"issue":"1","key":"10.1016\/j.amepre.2025.108102_bib0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1186\/s12884-020-03246-7","article-title":"Pregnancy vs. paycheck: a qualitative study of patient\u2019s experience with employment during pregnancy at high risk for preterm birth","volume":"20","author":"Wheeler","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"10.1016\/j.amepre.2025.108102_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.53317","article-title":"Trends in treatment need and receipt for substance use disorders in the U.S","volume":"8","author":"Liu","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amepre.2025.108102_bib0017","article-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2022 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality, 2024, Substance Abuse and Mental Health Services Administration","volume":"22","year":"2025"},{"issue":"8","key":"10.1016\/j.amepre.2025.108102_bib0018","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.amepre.2025.108102_bib0019","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40258-018-0416-4","article-title":"Friction cost estimates of productivity costs in cost-of-illness studies in comparison with human capital estimates: a review","volume":"16","author":"Pike","year":"2018","journal-title":"Appl Health Econ Health Policy"},{"issue":"6","key":"10.1016\/j.amepre.2025.108102_bib0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/13696998.2018.1542520","article-title":"Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations","volume":"22","author":"Grosse","year":"2019","journal-title":"J Med Econ"},{"key":"10.1016\/j.amepre.2025.108102_bib0021","unstructured":"Gross domestic product: implicit price deflator (GDPDEF). Federal Reserve Bank of St. Louis. https:\/\/fred.stlouisfed.org\/series\/GDPDEF#0. Updated August 29, 2024. Accessed January 15, 2025."},{"issue":"1","key":"10.1016\/j.amepre.2025.108102_bib0022","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/1475-6773.12612","article-title":"Adjusting health expenditures for inflation: a review of measures for health services research in the United States","volume":"53","author":"Dunn","year":"2018","journal-title":"Health Serv Res"},{"issue":"12","key":"10.1016\/j.amepre.2025.108102_bib0023","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.2337\/dc18-1179","article-title":"Economic costs attributable to diabetes in each U.S. state","volume":"41","author":"Shrestha","year":"2018","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.amepre.2025.108102_bib0024","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/01.jom.0000243406.08419.74","article-title":"Effect of smoking status on productivity loss","volume":"48","author":"Bunn","year":"2006","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.amepre.2025.108102_bib0025","unstructured":"Emergency department visits. National Center for Health Statistics, Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/nchs\/fastats\/emergency-department.htm. Updated September 6, 2022. Accessed January 4, 2025."},{"key":"10.1016\/j.amepre.2025.108102_bib0026","unstructured":"National health interview survey 1997\u20132018. National Center for Health Statistics, Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/nchs\/nhis\/1997-2018.htm. Updated XXX. Accessed December 10, 2025."},{"key":"10.1016\/j.amepre.2025.108102_bib0027","unstructured":"National Academies of Sciences Engineering and Medicine, Evidence on strategies for addressing the opioid epidemic, In: J.K. Phillips, M.A. Ford and R.J. Bonnie, Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use, 2017, National Academies Press (U.S.); Washington, DC. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK458653\/. Acessed June 25, 2024."},{"issue":"3","key":"10.1016\/j.amepre.2025.108102_bib0028","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.chc.2010.03.005","article-title":"Evidence-based interventions for preventing substance use disorders in adolescents","volume":"19","author":"Griffin","year":"2010","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"2","key":"10.1016\/j.amepre.2025.108102_bib0029","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4425","article-title":"Effective parenting interventions to reduce youth substance use: a systematic review","volume":"138","author":"Allen","year":"2016","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.amepre.2025.108102_bib0030","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1186\/s12889-021-11906-2","article-title":"Risk and protective factors of drug abuse among adolescents: a systematic review","volume":"21","author":"Nawi","year":"2021","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.amepre.2025.108102_bib0031","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1025940311556","article-title":"Community risk and protective factors and adolescent substance use","volume":"24","author":"Hays","year":"2003","journal-title":"J Prim Prev"},{"issue":"5","key":"10.1016\/j.amepre.2025.108102_bib0032","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11121-013-0413-7","article-title":"Prevention system mediation of communities that care effects on youth outcomes","volume":"15","author":"Brown","year":"2014","journal-title":"Prev Sci"},{"issue":"1","key":"10.1016\/j.amepre.2025.108102_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dr.2011.10.001","article-title":"Recent advances in research on school-based extracurricular activities and adolescent development","volume":"32","author":"Farb","year":"2012","journal-title":"Dev Rev"},{"issue":"4","key":"10.1016\/j.amepre.2025.108102_bib0034","doi-asserted-by":"crossref","first-page":"357.e9","DOI":"10.1016\/j.jadohealth.2006.10.013","article-title":"Social and school connectedness in early secondary school as predictors of late teenage substance use, mental health, and academic outcomes","volume":"40","author":"Bond","year":"2007","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.amepre.2025.108102_bib0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.addbeh.2017.11.020","article-title":"Patterns of adverse childhood experiences and substance use among young adults: a latent class analysis","volume":"78","author":"Shin","year":"2018","journal-title":"Addict Behav"},{"key":"10.1016\/j.amepre.2025.108102_bib0036","unstructured":"World Health Organization, United Nations Office on Drugs and Crime. Incorporating results of field-testing, International Standards for the Treatment of Drug Use Disorders, Revised Edition, 2020, World Health Organization and United Nations Office on Drugs and Crime; Geneva.https:\/\/www.unodc.org\/documents\/drug-prevention-and-treatment\/UNODC-WHO_International_Standards_Treatment_Drug_Use_Disorders_April_2020.pdf. Accessed June 22, 2025."},{"issue":"10","key":"10.1016\/j.amepre.2025.108102_bib0037","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1111\/add.15458","article-title":"Heroin use cannot be measured adequately with a general population survey","volume":"116","author":"Reuter","year":"2021","journal-title":"Addiction"},{"issue":"12","key":"10.1016\/j.amepre.2025.108102_bib0038","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2105\/AJPH.2018.304673","article-title":"Estimated prevalence of opioid use disorder in Massachusetts, 2011\u20132015: a capture\u2013recapture analysis","volume":"108","author":"Barocas","year":"2018","journal-title":"Am J Public Health"},{"issue":"12","key":"10.1016\/j.amepre.2025.108102_bib0039","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/aje\/kwac154","article-title":"Opioid use disorder among Ohio\u2019s Medicaid population: prevalence estimates from 19 counties using a multiplier method","volume":"191","author":"Doogan","year":"2022","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amepre.2025.108102_bib0040","article-title":"What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size","volume":"3","author":"Keyes","year":"2022","journal-title":"Drug Alcohol Depend Rep"},{"issue":"6","key":"10.1016\/j.amepre.2025.108102_bib0041","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/ADM.0000000000001375","article-title":"Improving estimates of the prevalence of opioid use disorder in the United States: revising Keyes et al","volume":"18","author":"Lim","year":"2024","journal-title":"J Addict Med"},{"key":"10.1016\/j.amepre.2025.108102_bib0042","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.annepidem.2021.12.013","article-title":"What is the prevalence of drug use in the general population? Simulating underreported and unknown use for more accurate national estimates","volume":"68","author":"Levy","year":"2022","journal-title":"Ann Epidemiol"},{"issue":"11","key":"10.1016\/j.amepre.2025.108102_bib0043","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1176\/appi.ajp.20240852","article-title":"Higher prevalence estimates of substance use disorders with DSM-5 versus DSM-IV criteria among U.S. nonelderly adults with substance use: the role of DSM-IV diagnostic orphans","volume":"181","author":"Hasin","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.amepre.2025.108102_bib0044","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/15622970309167951","article-title":"Cigarette-derived nicotine is not a medicine","volume":"4","author":"Parrott","year":"2003","journal-title":"World J Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.amepre.2025.108102_bib0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amepre.2025.108102_bib0046","doi-asserted-by":"crossref","first-page":"147","DOI":"10.15288\/jsa.2006.67.147","article-title":"Prevalence and distribution of alcohol use and impairment in the workplace: a U.S. national survey","volume":"67","author":"Frone","year":"2006","journal-title":"J Stud Alcohol"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379725005707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379725005707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:00:44Z","timestamp":1768910444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379725005707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0749379725005707"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2025.108102","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Productivity Losses From Substance Use Disorder in the U.S. in 2023","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2025.108102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108102"}}